Karmic Compounds logo
AX-2026-4775-D72Uv1
KC-NV10R4731 (Retatrutide) · Lot PS1-20260529-03 · Karmic Compounds
CRYPTOGRAPHICALLY SEALED
SHA-384: 1e9d48fb580fe549
Scan to verify
PRODUCT ATTRIBUTION
Karmic Compounds logo
Karmic Compounds
Brand identity verified
Submitted by: Karmic Compounds

Originated by Karmic Compounds, which attests it authorized this test as the brand of record.

Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.

Open / Print PDF
PASS — All specifications met4 of 4 layers complete
  • L1
    Identity
  • L2
    Purity
  • L3
    Net Peptide Content
  • L4
    Sterility
SAMPLE & VIAL VALIDATION
Vial A as received
Vial A: as received & analyzed
BrandKarmic Compounds
ProductKC-NV10R4731 (Retatrutide)
Lot / BatchPS1-20260529-03
Label Claim10 mg
Matrixlyophilized powder
Sample Count1
Vial Size3mL
Cap ColorWhite
Crimp ColorSilver / Aluminum
Contents ColorWhite
Seal IntactYes
Conditionsealed, intact

Test Results

Select a test for its full result
Referenceevery vial within ±1 Da of 4731.421 DaResult4731.421 DaPASS
ReferenceQualified purity criterion requiredResult99.79%PASS
Referenceevery vial within ±10% of 10 mgResultVial A: 10.68 mgPASS
ReferenceRapid PCR screenResultTarget DNA not detectedPASS

REPORTING SCOPE & LIMITATIONS

  • [Purity]The chromatographic trace was not retained for this certificate. The purity value and its acceptance limit are unaffected.
  • [Identity]The mass spectrum was not retained for this certificate. Identity is reported from the recorded accurate mass against its theoretical value.
  • [Sterility · Rapid PCR]DNA-target research screen only. It detects microbial DNA from viable and non-viable organisms alike, and is neither viable-CFU enumeration under USP <61> nor a batch sterility determination under USP <71>.
REVIEW & DIGITAL SIGNATURES
Analyst
Alana Reeves
ed25519:9639e15265adac8f07a38083...
Technical Reviewer
Michael Niles
ed25519:41d5805b45504ef4ba844b5d...
Laboratory Director
Daniel Brennan
ed25519:abf4456a3f0f23adda29ba5d...
Released Sep 6, 2026, 08:32 UTC
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-2026-4775-D72U
REPORTING SCOPE

Results relate only to the item or portion tested. Unless sampling was performed or witnessed by Axiom Analytics, the laboratory does not attest that the submitted sample represents the wider lot or batch. A PASS designation means only that the reported result met the specification shown. It does not establish safety, efficacy, regulatory approval, legality, or suitability for human or animal use.

RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

ANALYSIS & ACCREDITATION

Physical instrument analysis is performed at Axiom Analytics' discretion (based on method, capacity, and order volume), either in Axiom's own laboratory under its documented quality system or by an independent partner laboratory engaged under confidentiality. Where analysis is subcontracted, the method is performed within the partner laboratory's published ISO/IEC 17025 scope of accreditation for that method, not merely at a laboratory holding ISO/IEC 17025 accreditation. Axiom Analytics does not itself currently hold ISO/IEC 17025 accreditation. The method-validation status of each reported result is identified beside that result. Partner laboratory identities are not disclosed: samples are analyzed under double-blind conditions, identified only by an internal lot ID.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.